NIH IGNITE Program — R61/R33 Phased Neurotherapeutic Grants
Supports early neurotherapeutic translation through milestone-based translational funding.
The NINDS IGNITE program — Innovation Grants to Nurture Initial Translational Efforts — provides milestone-gated, phased R61/R33 funding for early-stage neurotherapeutic development, serving as the primary feeder into the later-stage NIH Blueprint Neurotherapeutics Network for small molecules (BPN) and BPN-Biologics. Three active NOFOs cover distinct development stages: PAR-25-059 (assay developme…
Early-stage neurotherapeutic development including assay development, model system validation, and agent characterization for small-molecule and biologic candidates targeting neurological diseases.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from NIH
All grants from this funder →Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI)
🇺🇸NIH · United States
Funds the design and early validation of frameworks — guidelines, protocols and standard procedures — for building and deploying multimodal medical AI reliably.
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers
🇺🇸NIH · United States
Funds a clinical centre inside a consortium testing how to use anti-obesity medication in children without harming their growth or mental health.
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center
🇺🇸NIH · United States
Funds the single centre that runs statistics, data and coordination for the consortium testing anti-obesity medication in children.
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)
🇺🇸NIH · United States
Funds work on the methodological problems that make trials of rapid-acting psychotropic drugs hard to interpret, and on sustaining the treatment afterwards.
Assay Validation of High Quality Markers for Clinical Studies in Cancer
🇺🇸NIH · United States
Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3)
🇺🇸NIH · United States
Funds the clinical validation of a cancer biomarker assay whose analytical performance has already been proven.
Similar grants
Browse the directory →
NIH SBIR Phase I
🇺🇸NIH SEED · United States
Funds early stage United States biomedical teams through NIH seed support for feasibility work on prototype ready ideas.
NCATS STTR Phase I
🇺🇸NCATS · United States
Funds U.S. small businesses and their nonprofit research partners to conduct feasibility studies on translational science innovations toward commercialization.
NEI SBIR Phase I — Feasibility
🇺🇸NEI · United States
Supports United States. small businesses testing vision concepts through feasibility-focused grants.
NEI STTR Phase I — Feasibility
🇺🇸NEI · United States
Funds small business and research-partner teams on feasibility vision tools for future commercialization.
US-Ireland R&D Partnership
🇮🇪HRB (Health Research Board Ire · Ireland
Connects United States and United Kingdom researchers through joint biomedical innovation grants.
Parkinson's Foundation Stanley Fahn Junior Faculty Award
🇺🇸Parkinson's Foundation · United States
Funds early-career Parkinson's disease researchers at United States and Canada institutions through independent investigator support.